MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.

    P. Singh, A. Gupta, A. Gupta (Delhi, India)

    Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…
  • 2024 International Congress

    Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study

    H. Abboud, R. Sun, N. Modak, M. Elkasaby, A. Wang, M. Levy (Cleveland, USA)

    Objective: Movement disorders secondary to spinal cord demyelination are the most frequent movement disorders in multiple sclerosis (MS). Retrospective studies and case series suggest that…
  • 2024 International Congress

    Movement Disorders in Autoimmune Encephalitis: A case series of 11 cases.

    G. Costa, C. Del Prado, A. Marin, I. Apaza, M. Bendersky, C. Simison, P. Hernandez, F. Echeverria, T. Arakaki, S. Rodriguez Quiroga, N. Garretto (CABA Buenos Aires, Argentina)

    Objective: Describe abnormal movements associated with autoimmune encephalopathies (AIE) Background: Movement disorders are a hallmark feature of autoimmune encephalitis (AIE), playing a pivotal role in…
  • 2024 International Congress

    The association of Severity and Monogenetic Subgroups in Parkinson’s Disease

    N. Pacheco-Barrios, K. Acurio, J. Rolston, T. Siepman, B. Illigens (Boston, USA)

    Objective: Explore how different genotypes can affect the disease severity and progression in Parkinson's patients. Background: Genetic advances have identified specific mutations linked to disease…
  • 2024 International Congress

    Anosognosia for hardware-related complications in deep brain stimulation

    F. Wolff Fernandes, J. Runge, A. Saryyeva, JK. Krauss (Hannover, Germany)

    Objective: In this series, we report two rare cases of selective unawareness to hardware-related complications in deep brain stimulation (DBS). Background: DBS has shown good…
  • 2024 International Congress

    Laboratory changes of the liver function in the patients with Wilson’s disease

    I. Voloshyn-Haponov, A. Teslenko, L. Cherkashyna, O. Korzh (Kharkiv, Ukraine)

    Objective: Wilson's disease (WD) is a chronic progressive neurodegenerative disease with a genetically determined disorder of copper metabolism due to mutations in the ATP7B gene,…
  • 2024 International Congress

    Muscle co-contraction in people with Parkinson’s disease suffering from freezing of gait

    D. Buzaglo, P. Gandhi, Y. Hanein, J. Hausdorff (Tel Aviv, Israel)

    Objective: 1) to test the feasibility of using novel, disposable EMG electrodes to study co-contraction (CC) and 2), to test if muscle CC is higher…
  • 2024 International Congress

    Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors

    K. Ho, C. Chen, S. Shin, S. Li, N. Kowahl, L. Evers, M. Meinders, L. Shih, B. Bloem, A. Siderowf, R. Kapur (South San Francisco, USA)

    Objective: To describe an approach using machine learning (ML) to develop composite digital measures that capture changes in physical activity in people with early-stage Parkinson’s…
  • 2024 International Congress

    Cardiovascular Risk Profile in Patients with Primary Familial Brain Calcification

    B. Snijders, M. Peters, P. de Jong, B. Lith, E. Brilstra, Y. Ruigrok, V. Schepers, E. van Valen, M. Emmelot-Vonk, H. Koek (Utrecht, Netherlands)

    Objective: To explore the cardiovascular risk profile of patients with Primary Familial Brain Calcification (PFBC) and Fahr’s syndrome. Background: PFBC, also known as Fahr’s disease,…
  • 2024 International Congress

    GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil

    F. Rolim, S. Lima, A. Verde, P. Matos, A. Marinho, F. Carvalho (Fortaleza, Brazil)

    Objective: To identify the prevalence of pathogenic variants of the GBA1 mutation among patients with parkinsonism who have undergone genetic testing. Background: GBA gene encodes…
  • « Previous Page
  • 1
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley